McMullen Carmit K, Safford Monika M, Bosworth Hayden B, Phansalkar Shobha, Leong Amye, Fagan Maureen B, Trontell Anne, Rumptz Maureen, Vandermeer Meredith L, Brinkman William B, Burkholder Rebecca, Frank Lori, Hommel Kevin, Mathews Robin, Hornbrook Mark C, Seid Michael, Fordis Michael, Lambert Bruce, McElwee Newell, Singh Jasvinder A
Center for Health Research, Kaiser Permanente Northwest, Portland, OR USA.
Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL USA.
Patient Educ Couns. 2015 Jan;98(1):102-10. doi: 10.1016/j.pec.2014.09.015. Epub 2014 Oct 13.
The Centers for Education and Research on Therapeutics convened a workshop to examine the scientific evidence on medication adherence interventions from the patient-centered perspective and to explore the potential of patient-centered medication management to improve chronic disease treatment.
Patients, providers, researchers, and other stakeholders (N = 28) identified and prioritized ideas for future research and practice. We analyzed stakeholder voting on priorities and reviewed themes in workshop discussions.
Ten priority areas emerged. Three areas were highly rated by all stakeholder groups: creating tools and systems to facilitate and evaluate patient-centered medication management plans; developing training on patient-centered prescribing for providers; and increasing patients' knowledge about medication management. However, priorities differed across stakeholder groups. Notably, patients prioritized using peer support to improve medication management while researchers did not.
Engaging multiple stakeholders in setting a patient-centered research agenda and broadening the scope of adherence interventions to include other aspects of medication management resulted in priorities outside the traditional scope of adherence research.
Workshop participants recognized the potential benefits of patient-centered medication management but also identified many challenges to implementation that require additional research and innovation.
治疗学教育与研究中心召开了一次研讨会，从以患者为中心的视角审视药物依从性干预措施的科学证据，并探讨以患者为中心的药物管理在改善慢性病治疗方面的潜力。
患者、医疗服务提供者、研究人员及其他利益相关者（共28人）确定了未来研究和实践的想法并排出优先顺序。我们分析了利益相关者对优先事项的投票情况，并回顾了研讨会讨论中的主题。
出现了10个优先领域。三个领域得到了所有利益相关者群体的高度评价：创建工具和系统以促进和评估以患者为中心的药物管理计划；为医疗服务提供者开展以患者为中心的处方培训；以及增加患者对药物管理的了解。然而，不同利益相关者群体的优先事项有所不同。值得注意的是，患者将利用同伴支持来改善药物管理列为优先事项，而研究人员则没有。
让多个利益相关者参与制定以患者为中心的研究议程，并将依从性干预措施的范围扩大到包括药物管理的其他方面，导致了超出传统依从性研究范围的优先事项。
研讨会参与者认识到以患者为中心的药物管理的潜在益处，但也指出了实施过程中存在的许多挑战，需要进一步的研究和创新。
